Atrasentan in Patients With Proteinuric Glomerular Diseases | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Atrasentan in Patients With Proteinuric Glomerular Diseases	Alport syndrome, Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Diabetes Complications, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Abnormalities, Urogenital Diseases, autoimmune disease, connective tissue disorder, diabetes mellitus, diabetic kidney disease, endocrine system disorder, focal segmental glomerulosclerosis, glomerulonephritis, hereditary nephritis, immune system disorder, kidney disorder, nephritis, urinary system disorder	Active, not recruiting	Phase 2	2026-06-01		NCT04573920

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Novartis Pharmaceuticals	432

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Academic Medical Research Institute	Los Angeles	United States	10
Baylor Scott and White	Dallas	United States	6
Brookview Hills Research Assoc	Winston-Salem	United States	1
Colorado Kidney Care Nephrology	Denver	United States	3
DaVita Clinical Research	Las Vegas	United States	3
Kidney Disease Medical Group	Glendale	United States	5
Milwaukee Nephrologists SC	Wauwatosa	United States	1
Mountain Kidney And Hyper Associa	Asheville	United States	1
North America Research Institute	San Dimas	United States	11
Northwest Louisiana Nephrology Research	Shreveport	United States	1
Prolato Clinical Research Center	Houston	United States	22
Stanford U School Of Medicine	Stanford	United States	1
Tufts Medical Center	Boston	United States	238
Uni of Minnesota Hos and Clinics	Minneapolis	United States	1